# Tuberculosis Surge in Southeast Asian Prisons Triggers WHO Emergency Response as Drug-Resistant Strains Spread

**GENEVA, Feb. 21** — The World Health Organisation launched an emergency coordinated response on Friday targeting what its infectious disease division described as an accelerating tuberculosis crisis across prison systems in six Southeast Asian countries, after epidemiological surveillance data compiled over the past eight months revealed that TB incidence rates within detention facilities in Myanmar, Cambodia, Laos, Vietnam, Thailand, and the Philippines had reached levels between fourteen and thirty-one times higher than the general population rates in the same countries, and that the proportion of cases involving drug-resistant strains — including extensively drug-resistant tuberculosis, for which treatment options are severely limited and mortality rates can exceed 40 percent — had risen sharply enough to represent what WHO epidemiologists described on Friday as a genuine threat of spillover transmission into broader community populations that current public health infrastructure in the affected countries would be unable to contain.

The emergency response, whose activation was confirmed by WHO Director-General Tedros Adhanom Ghebreyesus at a briefing in Geneva on Friday, will involve the deployment of rapid response teams to each of the six countries, the pre-positioning of diagnostic equipment including GeneXpert machines capable of detecting drug resistance within two hours rather than the weeks required by conventional culture methods, an emergency procurement of second and third-line TB drug regimens through the Stop TB Partnership's Global Drug Facility, and what Tedros described as "frank and urgent engagement" with the governments of affected countries on the structural conditions within their prison systems — severe overcrowding, malnutrition, inadequate ventilation, and limited healthcare access — that have created environments in which TB transmission occurs at rates that make individual treatment without systemic intervention essentially futile.

"You cannot treat your way out of an epidemic inside a closed population where transmission is continuous and the conditions that drive it remain unchanged," Tedros said. "Treatment is necessary but insufficient. The structural conditions must change and we will be saying that directly and without diplomatic hedging to the governments concerned."

The epidemiological data underpinning the emergency declaration, portions of which were shared with journalists under embargo on Thursday and whose full publication in the WHO's Weekly Epidemiological Record is scheduled for next Wednesday, document a situation that researchers who reviewed the material described as more severe than any comparable prison TB crisis documented in the peer-reviewed literature outside the former Soviet Union in the 1990s — a benchmark whose invocation by multiple scientists on Friday illustrated the gravity of their assessment.

Myanmar presents the most acute situation. The military government that seized power in the February 2021 coup has dramatically expanded the prison population through mass political detentions — the Assistance Association for Political Prisoners estimates more than 21,000 political prisoners are currently held — and has simultaneously reduced the budget allocation for prison healthcare by an estimated 60 percent compared with pre-coup levels. WHO access to Myanmar's prison system has been severely restricted since 2021, and the data underlying the emergency declaration was obtained through a combination of smuggled medical records, testimony from released prisoners, and satellite analysis of prison facility expansion, a methodology whose unusual character reflects the fundamental access problem that the response will need to overcome.

A senior WHO official familiar with the Myanmar data, speaking on condition of anonymity because diplomatic negotiations with Naypyidaw are ongoing, said the organisation's best estimate was that TB prevalence within Myanmar's larger detention facilities exceeded 3,000 cases per 100,000 prisoners — a rate that, if accurate, would represent one of the highest documented TB prevalence figures ever recorded in any confined population globally. "We have low confidence in the precision of that figure," the official acknowledged. "We have high confidence that the situation is catastrophic."

The military government in Naypyidaw did not respond to a request for comment. Myanmar's permanent representative to the United Nations in Geneva, whose mandate derives from the junta, declined to attend a briefing organised by WHO on Thursday for representatives of affected countries' missions, a snub that WHO officials interpreted as reflecting either hostility to scrutiny of prison conditions or internal uncertainty about how to engage with the emergency declaration.

The situation in the Philippines, while less severe than Myanmar's in absolute terms, carries its own particular dimensions. President Ferdinand Marcos Jr.'s administration inherited a prison system grotesquely overcrowded as a consequence of the Duterte government's drug war, whose mass arrests and prosecutions left facilities designed for 28,000 inmates holding more than 165,000 — a rate of overcrowding that ventilation engineers have described as making airborne disease transmission essentially uncontrollable regardless of other interventions. The Marcos government has acknowledged the prison population crisis and has initiated some releases and diversion programmes, but progress has been slow and the TB burden accumulated during the Duterte years continues to compound.

Health Secretary Teodoro Herbosa said on Friday that the Philippines welcomed WHO technical assistance and was "committed to addressing tuberculosis in all settings including detention facilities" and pointed to the government's implementation of a national TB elimination strategy as evidence of institutional seriousness. However, a senior official at the Philippine Coalition Against Tuberculosis, a civil society network, said the gap between the government's strategic commitments and its operational capacity to implement them within the prison system remained "enormous and inadequately funded."

The drug resistance dimension of the crisis carries implications that extend well beyond the prison walls. Extensively drug-resistant TB — defined as TB resistant to the most important first-line drugs and to at least one fluoroquinolone and one injectable second-line agent — is extraordinarily difficult and expensive to treat, requiring eighteen to twenty-four months of daily medication with drugs whose side effects include hearing loss, psychosis, and hepatotoxicity. In populations moving through and out of prisons — visitors, released inmates, guards — a drug-resistant strain circulating in a detention facility has pathways to community transmission that public health surveillance systems in the affected countries are not currently designed to detect quickly enough to interrupt.

Dr. Lucica Ditiu, executive director of the Stop TB Partnership, said on Friday that the emergence of drug-resistant strains in settings of high transmission density and inadequate treatment completion represented "a perfect incubator for the evolution of strains that could eventually render our current drug arsenal inadequate." She said the scenario her organisation feared most was not the current crisis but what it could become if the evolutionary pressure on the TB pathogen within the affected prison populations continued for another two to three years without structural intervention. "We are not at that point yet," she said. "We are on the path to it."

The financial architecture of the emergency response involves WHO's Contingency Fund for Emergencies, the Global Fund to Fight AIDS, Tuberculosis and Malaria — which has existing country programmes in all six affected nations — and bilateral emergency contributions that WHO said it was soliciting from member states with the capacity to respond quickly. The United States, through USAID, confirmed on Friday it was releasing $12 million in emergency TB funding for the region, specifically earmarking resources for diagnostic equipment and drug procurement rather than the broader structural interventions that WHO has identified as ultimately essential. A USAID spokesperson said additional funding was under review.

Human rights organisations used Friday's WHO declaration to focus attention on the conditions that have created the crisis. Amnesty International published a report on Friday — timed to coincide with the WHO announcement — documenting what it described as systematic neglect of healthcare obligations toward detained persons across the six affected countries, including accounts from former prisoners in Myanmar, Cambodia, and the Philippines of inmates dying from TB in cells without any medical attention, of sick prisoners denied transfer to hospital facilities, and of correctional authorities falsifying death records to avoid recording tuberculosis fatalities.

"This is not a natural disaster," said Amnesty's health and human rights researcher, Dr. Ines Osman, at a press briefing in London on Friday. "This is the predictable consequence of governments treating imprisoned people as beneath the concern of public health. The TB crisis in these prisons was created by policy choices and it can only be resolved by different policy choices."

Whether the governments concerned — ranging from Myanmar's military junta, for which international health engagement represents both a lifeline and a sovereignty problem, to democratic governments facing the politically difficult task of improving conditions for convicted prisoners — would make those different policy choices under the combination of WHO pressure, international attention, and disease threat is, as of Friday, an open question.

The WHO emergency response teams are expected to begin arriving in Thailand, Vietnam, and the Philippines — the three countries with the most established WHO country office capacity and the least restricted access — by the end of next week, with deployment to Cambodia and Laos following in the subsequent ten days. The Myanmar timeline remains subject to access negotiations whose outcome WHO officials described on Friday as genuinely uncertain.

*Additional reporting from Manila, Bangkok, and London.*